<- Go Home
Finch Therapeutics Group, Inc.
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States.
Market Cap
$19.5M
Volume
28.5K
Cash and Equivalents
$16.0M
EBITDA
-$19.5M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$14.26
52 Week Low
$0.80
Dividend
N/A
Price / Book Value
1.37
Price / Earnings
-1.38
Price / Tangible Book Value
1.37
Enterprise Value
$32.5M
Enterprise Value / EBITDA
-1.77
Operating Income
-$19.7M
Return on Equity
-67.28%
Return on Assets
-21.89
Cash and Short Term Investments
$16.0M
Debt
$29.0M
Equity
$14.2M
Revenue
N/A
Unlevered FCF
-$16.0M
Sector
Biotechnology
Category
N/A